Ginkgo Bioworks announced on May 21, 2025, that Mark Dmytruk, the company's Chief Financial Officer, intends to resign from his role on May 30, 2025. Steven Coen, Ginkgo's current Chief Accounting Officer, will succeed him as Chief Financial Officer, effective upon Mr. Dmytruk's resignation.
Mr. Coen joined Ginkgo on May 1, 2023, bringing over 30 years of public accounting and corporate finance leadership experience. His prior roles include Corporate Vice President and Corporate Controller for Charles River Laboratories, a global contract research organization.
This internal promotion ensures continuity in the company's financial leadership. Mr. Coen is expected to build upon the financial vision and strategy established, continuing the drive towards cost reduction targets and the goal of reaching Adjusted EBITDA breakeven by the end of 2026.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.